Factory high qunlity and low price DL-CYCLOSERINE
Price | USD1.00 |
Packge | 1g |
- Min. Order:100g
- Supply Ability:g/kg/Ton
- Time:2020-01-15
Product Details
- Product NameDL-CYCLOSERINE
- CAS No.68-39-3
- EINECS No.200-687-9
- MFC3H6N2O2
- MW102.09
- AppearancecrystallineWhite to Light Yellow
- storage temp. Keep in dark place,Sealed in dry,Store in freezer, under -20°C
- Melting point 147°C
- density 1.278±0.06 g/cm3(Predicted)
Heidi1389
Email:heidi@coreychem.com
▼
▲
DL-CYCLOSERINE Basic information
▼
▲
Product Name:
Synonyms:
DL-Cycloserine DL-Cycloserine;DL-Cycloserine crystalline;4-Amino-3-isoxazolidone;DL-Cyloserine;(+-)-4-amino-3-isossazolidone;DL-4-AMINO-3-ISOXAZOLIDINONE;DL-CYCLO-SER;DL-CYCLOSERINE
CAS:
MF:
C3H6N2O2
MW:
102.09
EINECS:
200-687-9
Product Categories:
Mol File:
▼
▲
DL-CYCLOSERINE Chemical Properties
▼
▲
Melting point
147°C
density
1.278±0.06 g/cm3(Predicted)
storage temp.
−20°C
form
crystalline
pka
14.36±0.40(Predicted)
▼
▲
Safety Information
▼
▲
WGK Germany
3
RTECS
NY2974900
▼
▲
Provider
Language
English
▼
▲
DL-CYCLOSERINE Usage And Synthesis
▼
▲
Chemical Properties
Off-White Solid
Uses
Antibacterial (tuberculostatic).
Definition
ChEBI: A member of the class of oxazolidines that is isoxazoldin-3-one which is substituted at position 4 by an amino group.
▼
▲
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates:
Pharmaceutical intermediates;
OLED intermediates;
Recommended supplier
-
VIP1年
- JSK Chemicals
- 68-39-3 DL-Cycloserine, 97% 99%
- Inquiry
- 2023-12-22
-
VIP1年
- Blue Jet Healthcare Ltd
- 68-41-7 Cycloserine >98%
- Inquiry
- 2024-07-06
-
VIP1年
- Solara Active Pharma Sciences Ltd
- Cycloserine 98%
- Inquiry
- 2024-01-23
-
VIP1年
- Varanous Labs Pvt Ltd
- L-Cycloserine 339-72-0 98%
- Inquiry
- 2023-12-26
- Since:2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY